November 21, 2026 · Chest · DOI: 10.1016/j.chest.2026.11.015

Combination acetazolamide and supplemental oxygen markedly improves ventilatory control instability and OSA severity.

Listen to this summary

This randomized, single-blind crossover trial asked whether combining acetazolamide (500 mg daily) with supplemental oxygen could lower ventilatory control instability (loop gain) and OSA severity more than either treatment alone. In 22 adults with moderate-severe OSA, the combination markedly reduced loop gain beyond either monotherapy and cut the flow-based AHI by roughly 55%, though this AHI reduction was not significantly greater than acetazolamide alone. The authors conclude that the combination is a potent loop-gain-lowering strategy that may benefit patients whose OSA is largely driven by ventilatory control instability.

Shane A Landry, Simon A Joosten, Jinny Collet, Toshi Preston, Luke D J Thomson, Caroline J Beatty, Trisha Emperado, Dwayne Mann, Ai-Ming Wong, Anthony Turton, Scott A Sands, Garun S Hamilton, Bradley A Edwards

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play